Navigation Links
ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Date:1/25/2008

TORONTO, Jan. 25 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced it will hold a conference call to discuss its fourth quarter and year end 2007 results at 8:00 a.m. (Eastern Time) on Tuesday, January 29, 2008. The Company will report its results in a press release to be issued at 7:00 a.m. prior to the call.

DATE: Tuesday, January 29, 2008

TIME: 8:00 a.m., Eastern Standard Time

WEBCAST: A live audio webcast of the call will be available at http://www.ariusmabs.com. Webcast attendees are welcome to listen to the conference in real-time or on-demand at their convenience. The webcast will be archived for 365 days. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast.

TAPED REPLAY: 416-644-3414 or 1-800-731-6941 (Available until

February 5, 2008)

REFERENCE NUMBER: 21261080

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Forward-Looking Statements

Certain statements in this news release constitute
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
2. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
3. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
4. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
5. ARIUS to present at Chinese Global Financial Forum
6. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
7. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
8. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
9. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
11. VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... January 14, 2014 iLab Solutions, the leader ... the new Director of Product Strategy. In this role, Michelle ... iLab sub-teams to guide in the development of iLab products. ... the maximum possible benefit to the scientific community by offering ...
(Date:1/14/2014)... 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a ... innovative therapies addressing major unmet medical needs using ... Notice of Allowance from the United States Patent ... compounds (sd-rxRNA®), for the treatment of fibrosis. The ...
(Date:1/14/2014)... , Jan. 14, 2014   Kinaxis ®, provider of ... ) and sales and operations planning ( S&OP ) service, ... Biomanufacturing Summit , which will be held at the Hilton ... conference, join Kinaxis customer Elisabeth Kaszas , Director of ...
(Date:1/14/2014)... 14, 2014 Kerr Corporation, a leading manufacturer ... additional how-to information about dual arch impressions on its dental ... Arch Impressions,” the blog entry serves up a list of ... a step-by-step demonstration by Dr. David Little as he crafts ...
Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... 1 Iomai Corporation,(Nasdaq: IOMI ) ... merger of,Iomai with a wholly-owned subsidiary of ... shares entitled to vote at the special,meeting ... of the,votes cast. The transaction remains subject ...
... MS, EDMONTON, Aug. 1 /PRNewswire-FirstCall/ - BioMS ... treatment of multiple sclerosis (MS), today,announced that it ... trial of MBP8298 (dirucotide) for the treatment of ... approximately,510 patients, and is being conducted at 68 ...
... Associates has announced the development of the Core Communications Program, ... investors, collaborators, and customers. , ... ... http://www.mainsgate.com [Mains Associates] has announced the availability of ...
Cached Biology Technology:BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 2BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 3BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 4Bay-Area Company Gives Science-Based Startups a Voice 2
(Date:7/9/2014)... the bladders of healthy women differ from bacteria ... according to researchers from Loyola University Chicago Stritch ... July 9, 2014, in the American Society for ... bacterial communities may play a role in female ... a common, yet poorly understood, condition with symptoms ...
(Date:7/9/2014)... associate professor of plant pathology and microbiology ... the 2014 Alexopoulos Prize by the Mycological ... the science of mycology the study of fungi ... plant pathogens, and medically important fungi. , The award ... mycologist. Stajich received the award last month in East ...
(Date:7/9/2014)... As climate change shifts the geographic ranges in which ... it has on their parasites. Does an increased range ... as well? , Not necessarily, says a team of ... Armand Kuris. In a study published in the ... that for some species, the opposite may happen: Hosts ...
Breaking Biology News(10 mins):UC Riverside plant pathologist receives national recognition 2Not at home on the range 2Not at home on the range 3Not at home on the range 4
... COLUMBUS, Ohio Ohio State University cancer researchers ... brain-tumor cells and blocks the growth of new tumor ... to kill cancer cells oncolytic viruses might ... also carry a gene for a protein that inhibits ...
... NEW YORK, Dec. 1 iQor, a global provider of business ... 100 Awards Top 100 IT project of 2009 for its ... , "We are honored to be recognized among this prestigious list ... is completely transforming the way we do business, allowing us to ...
... bad cold, can spread among groups of people, research ... Diego and Harvard shows. Using longitudinal data from a ... more than 60 years, a team of scholars found ... others. Gradually over time, a group of lonely, disconnected ...
Cached Biology News:Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3
... 26] to Presenilin 2 Alzheimer's disease ... the disease carry mutations in the presenilin ... protein (APP). These disease-linked mutations result in ... amyloid-beta (main component of amyloid deposits found ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
Biology Products: